The European Cancer Congress (ECC 2015), Discussing Cancer Prevention, Diagnosis, Treatment and Patient Care at the Highest Level, Begins Tomorrow in Vienna

Congresses are festivals of scientific research. They are festive meetings where almost everyone engaged in science gathers, shares experience, excitement and knowledge, and shapes the future. Hundreds of oncology congresses on cancer prevention, diagnosis, treatment and patient care take place worldwide each year. Two stand out as the venues where the most important cancer developments are shared. The first is ASCO, held annually in the last week of May in Chicago, America. The second is the European Cancer Congress (ECC 2015), beginning tomorrow in Vienna, Austria. Although it coincides with our Eid al-Adha holiday this year, my team and I will sacrifice our holiday to attend, see the most important developments closely and share them with you.
We believe the main topic at ECC 2015, starting tomorrow, will be immunotherapy, as at ASCO 2015. As the face of cancer medicine illuminating the future, immunotherapy continues to show effectiveness in almost all cancer types. I am delighted to share that at our clinic, for some non-small cell lung cancer patients, we have started using one of the 3 immunotherapy drugs, Nivolumab (Opdivo), through an early access program. Hopefully we will soon share successful results. Our goals include becoming the center applying cancer immunotherapy most proficiently in our country...
Alongside treatment and patient care, we expect cancer prevention and early diagnosis to receive extensive discussion at the European Cancer Congress.
Goodbye for now, until we meet again with encouraging and hopeful news...
Was this article helpful?
Your feedback helps us improve our content.





Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.